Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Biochemical characterization and stability of immune globulin intravenous 10% liquid (Panzyga®).

Mersich C, Ahrer K, Buchacher A, Ernegger T, Kohla G, Kannicht C, Pock K, Römisch J.

Biologicals. 2017 Jan;45:33-38. doi: 10.1016/j.biologicals.2016.10.003. Epub 2016 Oct 27.

2.

Elevated Endotoxin Levels in Human Intravenous Immunoglobulin Concentrates Caused by (1->3)-{beta}-D-Glucans.

Buchacher A, Krause D, Wiry G, Weinberger J.

PDA J Pharm Sci Technol. 2010 Nov-Dec;64(6):536-44.

PMID:
21502064
3.

Anticomplementary activity of IVIG concentrates--important assay parameters and impact of IgG polymers.

Buchacher A, Schluga P, Müllner J, Schreiner M, Kannicht C, Weinberger J.

Vox Sang. 2010 Apr;98(3 Pt 1):e209-18.

PMID:
20432511
4.

Purification of intravenous immunoglobulin G from human plasma--aspects of yield and virus safety.

Buchacher A, Iberer G.

Biotechnol J. 2006 Feb;1(2):148-63. Review.

PMID:
16892245
5.

Isolation of esterified fatty acids bound to serum albumin purified from human plasma and characterised by MALDI mass spectrometry.

Belgacem O, Stübiger G, Allmaier G, Buchacher A, Pock K.

Biologicals. 2007 Mar;35(1):43-9. Epub 2006 Mar 31.

PMID:
16580227
6.

Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering.

Ahrer K, Buchacher A, Iberer G, Jungbauer A.

J Biochem Biophys Methods. 2006 Mar 31;66(1-3):73-86. Epub 2006 Jan 19.

PMID:
16458360
7.

Effect of oriented or random PEGylation on bioactivity of a factor VIII inhibitor blocking peptide.

Kopecky EM, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A.

Biotechnol Bioeng. 2006 Mar 5;93(4):647-55.

PMID:
16395719
8.

Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.

Kopecky EM, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A.

J Immunol Methods. 2006 Jan 20;308(1-2):90-100. Epub 2005 Dec 5.

PMID:
16376372
9.

Combinatorial peptides directed to inhibitory antibodies against human blood clotting factor VIII.

Kopecky EM, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A.

Thromb Haemost. 2005 Nov;94(5):933-41.

PMID:
16363233
10.
11.
12.

Detection of aggregate formation during production of human immunoglobulin G by means of light scattering.

Ahrer K, Buchacher A, Iberer G, Jungbauer A.

J Chromatogr A. 2004 Jul 16;1043(1):41-6.

PMID:
15317411
13.

Characterization of antithrombin III from human plasma by two-dimensional gel electrophoresis and capillary electrophoretic methods.

Kremser L, Brückner A, Heger A, Grunert T, Buchacher A, Josic D, Allmaier G, Rizzi A.

Electrophoresis. 2003 Dec;24(24):4282-90.

PMID:
14679575
14.

Analysis of aggregates of human immunoglobulin G using size-exclusion chromatography, static and dynamic light scattering.

Ahrer K, Buchacher A, Iberer G, Josic D, Jungbauer A.

J Chromatogr A. 2003 Aug 15;1009(1-2):89-96.

PMID:
13677648
16.

Preparation of vitamin K-dependent proteins, such as clotting factors II, VII, IX and X and clotting inhibitor protein C.

Josic D, Hoffer L, Buchacher A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jun 25;790(1-2):183-97. Review.

PMID:
12767331
17.

Application of semi-industrial monolithic columns for downstream processing of clotting factor IX.

Branović K, Buchacher A, Barut M, Strancar A, Josic D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jun 25;790(1-2):175-82.

PMID:
12767330
18.
19.

Very fast analysis of impurities in immunoglobulin concentrates using conjoint liquid chromatography on short monolithic disks.

Branovic K, Lattner G, Barut M, Strancar A, Josic Dj, Buchacher A.

J Immunol Methods. 2002 Dec 20;271(1-2):47-58.

PMID:
12445728
20.

Continuous purification of a clotting factor IX concentrate and continuous regeneration by preparative annular chromatography.

Iberer G, Schwinn H, Josic D, Jungbauer A, Buchacher A.

J Chromatogr A. 2002 Sep 27;972(1):115-29.

PMID:
12395951
21.

Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.

Heger A, Grunert T, Schulz P, Josic D, Buchacher A.

Thromb Res. 2002 Apr 15;106(2):157-64.

PMID:
12182916
22.

Application of monoliths as supports for affinity chromatography and fast enzymatic conversion.

Josić D, Buchacher A.

J Biochem Biophys Methods. 2001 Oct 30;49(1-3):153-74. Review.

PMID:
11694278
23.

Characterization of clotting factor IX in plasma-derived preparations by electrophoretic techniques.

Pock K, Buchacher A, Rizzi A, Josić D.

J Chromatogr A. 2001 Jun 29;921(1):57-67.

PMID:
11461014
24.

Improved performance of protein separation by continuous annular chromatography in the size-exclusion mode.

Iberer G, Schwinn H, Josić D, Jungbauer A, Buchacher A.

J Chromatogr A. 2001 Jun 29;921(1):15-24.

PMID:
11461008
25.

Vitronectin in clotting factor IX concentrates.

Josic D, Kannicht C, Löster K, Pock K, Iberer G, Buchacher A.

Haemophilia. 2001 May;7(3):250-7.

PMID:
11380628
26.

Monoliths as stationary phases for separation of proteins and polynucleotides and enzymatic conversion.

Josic D, Buchacher A, Jungbauer A.

J Chromatogr B Biomed Sci Appl. 2001 Mar 10;752(2):191-205. Review.

PMID:
11270861
27.

Continuous removal of protein aggregates by annular chromatography.

Buchacher A, Iberer G, Jungbauer A, Schwinn H, Josic D.

Biotechnol Prog. 2001 Jan-Feb;17(1):140-9.

PMID:
11170492
28.

Application of monoliths for downstream processing of clotting factor IX.

Branović K, Buchacher A, Barut M, Strancar A, Josić D.

J Chromatogr A. 2000 Dec;903(1-2):21-32.

PMID:
11153943
29.

Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity.

Josić D, Hoffer L, Buchacher A, Schwinn H, Frenzel W, Biesert L, Klöcking HP, Hellstern P, Rokicka-Milewska R, Klukowska A.

Thromb Res. 2000 Dec 1;100(5):433-41.

PMID:
11150587
30.

Degradation products of factor VIII which can lead to increased immunogenicity.

Josić D, Buchacher A, Kannicht C, Lim YP, Löster K, Pock K, Robinson S, Schwinn H, Stadler M.

Vox Sang. 1999;77 Suppl 1:90-9. Review.

PMID:
10529698
31.

High-performance capillary electrophoresis for in-process control in the production of antithrombin III and human clotting factor IX.

Buchacher A, Schulz P, Choromanski J, Schwinn H, Josic D.

J Chromatogr A. 1998 Apr 10;802(2):355-66.

PMID:
9595697
32.

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5.

Purtscher M, Trkola A, Grassauer A, Schulz PM, Klima A, Döpper S, Gruber G, Buchacher A, Muster T, Katinger H.

AIDS. 1996 Jun;10(6):587-93.

PMID:
8780812
33.

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.

Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, Srinivasan K, Sodroski J, Moore JP, Katinger H.

J Virol. 1996 Feb;70(2):1100-8.

34.

DNA clearance in chromatography of proteins, exemplified by affinity chromatography.

Tauer C, Buchacher A, Jungbauer A.

J Biochem Biophys Methods. 1995 Feb;30(1):75-8.

PMID:
7608472
35.

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F, Tauer C, Berger R, Barrett N, Jungbauer A, et al.

AIDS Res Hum Retroviruses. 1994 Dec;10(12):1651-8.

PMID:
7888224
36.

Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.

Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M, Gruber G, Tauer C, Steindl F, Jungbauer A, et al.

AIDS Res Hum Retroviruses. 1994 Apr;10(4):359-69.

PMID:
7520721
37.

Displacement effects in large-scale chromatography?

Jungbauer A, Uhl K, Schulz P, Tauer C, Gruber G, Steindl F, Buchacher A, Schoenhofer W, Unterluggauer F.

Biotechnol Bioeng. 1992 Mar 5;39(5):579-87.

PMID:
18600985
38.

Isolation of isoproteins from monoclonal antibodies and recombinant proteins by chromatofocusing.

Jungbauer A, Tauer C, Wenisch E, Uhl K, Brunner J, Purtscher M, Steindl F, Buchacher A.

J Chromatogr. 1990 Jul 20;512:157-63.

PMID:
2229225
39.

Comparison of protein A, protein G and copolymerized hydroxyapatite for the purification of human monoclonal antibodies.

Jungbauer A, Tauer C, Reiter M, Purtscher M, Wenisch E, Steindl F, Buchacher A, Katinger H.

J Chromatogr. 1989 Aug 4;476:257-68.

PMID:
2777978
40.

Pilot scale production of a human monoclonal antibody against human immunodeficiency virus HIV-1.

Jungbauer A, Tauer C, Wenisch E, Steindl F, Purtscher M, Reiter M, Unterluggauer F, Buchacher A, Uhl K, Katinger H.

J Biochem Biophys Methods. 1989 Aug-Sep;19(2-3):223-40.

PMID:
2584609
41.

Scaleup of monoclonal antibody purification using radial streaming ion exchange chromatography.

Jungbauer A, Unterluggauer F, Uhl K, Buchacher A, Steindl F, Pettauer D, Wenisch E.

Biotechnol Bioeng. 1988 Jul 20;32(3):326-33.

PMID:
18584753

Supplemental Content

Loading ...
Support Center